Cowen and Company’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Hold |
0
| – | – | – | 645 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 609 |
|
|
2021
Q4 | – | Sell |
-400,000
| Closed | -$50.3M | – | 587 |
|
|
2021
Q3 | $50.3M | Sell |
400,000
-48,702
| -11% | -$6.12M | 2.38% | 7 |
|
|
2021
Q2 | $60.8M | Buy |
448,702
+46,208
| +11% | +$6.26M | 3.17% | 7 |
|
|
2021
Q1 | $54.6M | Buy |
402,494
+322,494
| +403% | +$43.7M | 3.75% | 6 |
|
|
2020
Q4 | $11.3M | Hold |
80,000
| – | – | 1.01% | 17 |
|
|
2020
Q3 | $8.91M | Hold |
80,000
| – | – | 1.46% | 11 |
|
|
2020
Q2 | $8.96M | Buy |
+80,000
| New | +$8.96M | 1.49% | 8 |
|
|
2020
Q1 | – | Sell |
-400,000
| Closed | -$38M | – | 368 |
|
|
2019
Q4 | $38M | Buy |
+400,000
| New | +$38M | 3.3% | 6 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 340 |
|